JOHNSON DAVID EDWARD

Average Profitability
0.09%
Insider Buys Quantity
16
Insider Buys Sum
$30.03M
Insider Sells Quantity
1
Insider Sells Sum
$2.6M

Insider Activity of JOHNSON DAVID EDWARD

According to the SEC Form 4 filings, JOHNSON DAVID EDWARD, being in a position of

  1. director at Exelixis, Inc.,
    оver the last 12 months, has bought 615000 shares for $12.67M, and sold 0 shares,
    over all time since 2023-11-27, has bought 735409 shares for $15.27M, and sold 120409 shares for $2.6M.

The largest purchase of all time was on 2022-04-18 and amounted to 1764705 shares of Liquidia Corporation for $9M.

The largest sale of all time was on 2023-11-27 and amounted to 120409 shares of Exelixis, Inc. for $2.6M.

Biography of JOHNSON DAVID EDWARD

No biography is available at this moment.

2024-05-30PurchaseExelixis, Inc.
EXEL
director
225,000
0.0772%
$20.76$4.67M+26.61%
2024-05-28PurchaseExelixis, Inc.
EXEL
director
200,000
0.0686%
$20.32$4.06M+29.48%
2024-02-21PurchaseExelixis, Inc.
EXEL
director
190,000
0.0626%
$20.70$3.93M+14.38%
2023-11-27SaleExelixis, Inc.
EXEL
director
120,409
0.0387%
$21.61$2.6M+6.55%
2023-11-27PurchaseExelixis, Inc.
EXEL
director
120,409
0.0387%
$21.61$2.6M+6.55%
2022-09-06PurchaseLiquidia Corporation
LQDA
250,000
0.3878%
$5.62$1.41M+21.8%
2022-08-03PurchaseStandard BioTools Inc.
LAB
46,009
0.0117%
$1.74$80,056+2.29%
2022-07-29PurchaseStandard BioTools Inc.
LAB
210,200
0.0454%
$1.48$311,096+22.41%
2022-06-13PurchaseStandard BioTools Inc.
LAB
100,000
0.0248%
$1.70$170,000-4.02%
2022-06-02PurchaseStandard BioTools Inc.
LAB
200,000
0.0561%
$1.92$384,000-16.08%
2022-05-25PurchaseLiquidia Corporation
LQDA
79,400
0.1189%
$3.40$269,960+63.01%
2022-05-17PurchaseLiquidia Corporation
LQDA
85,000
0.1322%
$5.81$493,850-2.5%
2022-05-06PurchaseStandard BioTools Inc.
LAB
463,350
0.1962%
$2.90$1.34M-43.05%
2022-04-28PurchaseStandard BioTools Inc.
LAB
125,000
0.0513%
$2.81$351,250-34.62%
2022-04-18PurchaseLiquidia Corporation
LQDA
1.76M
2.816%
$5.10$9M+9.53%
2022-04-11PurchaseStandard BioTools Inc.
LAB
50,000
0.0263%
$3.60$180,000-54.92%
2022-04-06PurchaseStandard BioTools Inc.
LAB
200,000
0.1133%
$3.88$776,000-54.21%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.